Greater Cannabis Company (GCAN) Shares Outstanding (Weighted Average) (2016 - 2026)

Greater Cannabis Company (GCAN) recorded quarterly Shares Outstanding (Weighted Average) of $944935.0 in Q1 2026, up 14.54% quarter-over-quarter from $824984.0 in Q4 2025, and down 99.9% on a YoY basis from $910.4 million in Q1 2025.

Greater Cannabis Company (GCAN) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends

Greater Cannabis Company's Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $944935.0 for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 99.9% year-over-year to $944935.0; the TTM figure through Mar 2026 stood at $944935.0 (down 99.9% YoY), while the FY2025 annual figure was $824984.0, up 53.74% from the prior year.
  • Shares Outstanding (Weighted Average) was $944935.0 for Q1 2026 at Greater Cannabis Company, up from $824984.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q2 2025 to a low of $536622.0 in Q3 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $525.3 million across 5 years, with a median of $617.9 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 99.93% in 2024, then surged 59.92% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $587.8 million in 2022, then increased by 28.48% to $755.2 million in 2023, then plunged by 99.93% to $536622.0 in 2024, then jumped by 53.74% to $824984.0 in 2025, then rose by 14.54% to $944935.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $944935.0 (Q1 2026), $824984.0 (Q4 2025), and $788524.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Greater Cannabis Company - - - 944,935.00

Historic Data

Download Data
DateValue
Mar 31, 2026 944,935.00
Dec 31, 2025 824,984.00
Sep 30, 2025 788,524.00
Jun 30, 2025 1.29 Bn
Mar 31, 2025 910.37 Mn
Dec 31, 2024 536,622.00
Sep 30, 2024 536,622.00
Jun 30, 2024 804.64 Mn
Mar 31, 2024 732.64 Mn
Dec 31, 2023 755.15 Mn
Sep 30, 2023 743.97 Mn
Jun 30, 2023 732.64 Mn
Mar 31, 2023 732.64 Mn
Dec 31, 2022 587.77 Mn
Sep 30, 2022 617.92 Mn
Jun 30, 2022 512.81 Mn
Mar 31, 2022 508.64 Mn
Dec 31, 2021 489.50 Mn
Sep 30, 2021 483.12 Mn
Jun 30, 2021 478.19 Mn